Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.85
-0.36 (-5.73%)
Aug 14, 2025, 2:21 PM - Market open

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
989610712--
Market Cap Growth
4.26%-10.29%769.50%---
Enterprise Value
71659624--
Last Close Price
6.205.737.414.74--
PS Ratio
238.0326.9417.78---
PB Ratio
3.662.422.99-1.46--
P/TBV Ratio
3.572.422.99---
EV/Sales Ratio
168.2918.2015.97---
Debt / Equity Ratio
----1.54--
Asset Turnover
0.010.080.24---
Quick Ratio
6.6110.227.941.553.7819.51
Current Ratio
7.4311.598.151.883.9919.57
Return on Equity (ROE)
-63.99%-39.57%-58.64%--81.90%-
Return on Assets (ROA)
-38.53%-25.15%-18.53%-88.03%-44.96%-
Return on Capital (ROIC)
-44.48%-28.63%-22.88%-141.30%-50.96%-
Earnings Yield
-20.13%-15.54%-7.49%-99.77%--
FCF Yield
-16.31%-10.75%-10.48%-58.99%--
Buyback Yield / Dilution
-29.13%-49.93%-292.40%-0.01%-40.88%-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q